Behçet syndrome: the vascular cluster

Abstract: Although skin-mucosa lesions are common in almost all patients with Behçet syndrome (BS), clinical properties may differ from one patient to another. Within BS, there are subsets with different organ involvement and hence probably different pathological pathways. These subsets can be described as a) solo skin-mucosa disease with no major organ involvement, b) eye disease, c) seronegative spondyloarthropathy-like disease (arthritis, enthesopathy, and folliculitis), d) Crohn-like disease, and finally the topic of this chapter: e) vascular disease. In the vascular disease subset, not surprisingly, several types of vascular involvement may be observed in the same individual. These subsets may make up the total clinical picture all at the same time or step by step with each relapse. Significant correlations exist between cerebral vascular thrombosis and pulmonary artery involvement, intracardiac thrombi and pulmonary artery involvement, Budd Chiari syndrome, and inferior vena cava syndrome. Lower extremity vein thrombosis is often present in these associations and even precedes them. The recognition of these clusters is not only important in diagnosis and management but also in basic science, including genetic studies.

PDF

___

1. Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations in Turkish patients with Behçets disease: a cross sectional study by exploratory factor analysis. J Rheumatol 2002; 29: 2393-296.
2. Krause I, Leibovici L, Guedj D, Molad Y, Uziel Y, Weinberger A. Disease patterns of patients with Behçets disease demonstrated by factor analysis. Clin Exp Rheumatol 1999; 17: 347-350.
3. Tunc R, Saip S, Siva A, Yazici H. Cerebral venous thrombosis is associated with major vessel disease in Behçets syndrome. Ann Rheum Dis 2004; 63: 1693-1694.
4. Hamuryudan V, Yurdakul S, Moral F, Numan F, Tüzün H, Tüzüner N, Mat C, Tüzün Y, Ozyazgan Y, Yazici H. Pulmonary arterial aneurysms in Behçets syndrome: a report of 24 cases. Br J Rheumatol 1994; 33: 48-51.
5. Hamuryudan V, Er T, Seyahi E, Akman C, Tüzün H, Fresko I, Yurdakul S, Numan F, Yazici H. Pulmonary artery aneurysms in Behçet syndrome. Am J Med. 2004; 117: 867-870.
6. Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, Yurdakul S, Tuzun H, Oz B, Yazici H. Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore) 2012; 91: 35-48.
7. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behçets syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 2014; 53: 2018-2022.
8. Tuzun H, Seyahi E, Arslan C, Hamuryudan V, Besirli K, Yazici H. Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease. J Vasc Surg 2012; 55: 157-163.
9. Yazici H, Ugurlu S, Seyahi E. Behçet syndrome: is it one condition? Clin Rev Allergy Immunol 2012; 43: 275-280.
10. Seyahi E, Baskurt M, Melikoglu M, Akman C, Olgun DC, Simsek E, Hamuryudan V, Kucukoglu S, Yazici H. The estimated pulmonary artery pressure can be elevated in Behçets syndrome. Respir Med 2011; 105: 1739-1747.
11. Seyahi E, Caglar E, Ugurlu S, Kantarci F, Hamuryudan V, Sonsuz A, Melikoglu M, Yurdakul S, Yazici H. An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçets syndrome followed up at a single, dedicated center. Semin Arthritis Rheum 2015; 44: 602-609.
12. Seyahi E, Cakmak OS, Tutar B, Arslan C, Dikici AS, Sut N, Kantarci F, Tuzun H, Melikoglu M, Yazici H. Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behcet syndrome: an observational study. Medicine (Baltimore) 2015; 94: e1899.
13. Seyahi E, Yazici H. To anticoagulate or not to anticoagulate vascular thrombosis in Behçets syndrome: an enduring question. Clin Exp Rheumatol 2016; 34(1 Suppl 95): S3-4.
14. Desbois AC, Wechsler B, Resche-Rigon M, Piette JC, Huong Dle T, Amoura Z, Koskas F, Desseaux K, Cacoub P, Saadoun D. Immunosuppressants reduce venous thrombosis relapse in Behçets disease. Arthritis Rheum 2012; 64: 2753-2760.
15. Alibaz-Oner F, Karadeniz A, Yılmaz S, Balkarlı A, Kimyon G, Yazıcı A, Çınar M, Yılmaz S, Yıldız F, Yaşar Bilge Ş et al. Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine (Baltimore) 2015; 94: e494.74.
16. Seyahi E, Yazici H. Atherosclerosis in Behçets syndrome. Clin Exp Rheumatol 2007; 25(4 Suppl 45): S1-5.
17. Merashli M, Ster IC, Ames PR. Subclinical atherosclerosis in Behcets disease: a systematic review and meta-analysis. Semin Arthritis Rheum 2016; 45: 502-510.
18. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76.
19. Seyahi E, Memisoglu E, Hamuryudan V, Tepe S, Aker UT, Balci H, Ongen Z, Yurdakul S, Yazici H. Coronary atherosclerosis in Behçets syndrome: a pilot study using electron-beam computed tomography. Rheumatology (Oxford) 2004; 43: 1448-1450.
20. Seyahi E, Ugurlu S, Cumali R, Balci H, Ozdemir O, Melikoglu M, Hatemi G, Fresko I, Hamuryudan V, Yurdakul S et al. Atherosclerosis in Behçets syndrome. Semin Arthritis Rheum 2008; 38: 1-12.
21. Ugurlu S, Seyahi E, Yazici H. Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcets syndrome. Rheumatology (Oxford) 2008; 47: 472-475.